Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Background and Aims: The prevalence of hepatitis C virus infection (HCV) infection in Punjab,
India is 3.29%, with an estimated burden of around 650,000 viremic chronic HCV (CHC)
patients. The Mukh Mantri Punjab Hepatitis C Relief Fund (MMPHCRF) was launched in June 2016
to provide free treatment to all CHC aiming to eliminate HCV from Punjab. The study assessed
the feasibility of decentralized care and efficacy and safety of 12 or 24 weeks of sofosbuvir
(SOF) + ledipasvir (LDV) or SOF + daclatasvir (DCV) ± ribavirin (RBV) in the treatment of CHC
patients in a public health care setting.
Phase:
N/A
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research